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ABSTRACT
Autophagy is a catabolic pathway required for cellular and organism homeostasis. Autophagy
participates in the innate and adaptive immune responses at different levels. Xenophagy is a class
of selective autophagy that involves the elimination of intracellular pathogens. Trypanosoma cruzi
is the causative agent of Chagas, a disease that affects 8 million individuals worldwide. Previously,
our group has demonstrated that autophagy participates in the invasion of T. cruzi in non-
phagocytic cells. In this work we have studied the involvement of autophagy in the development
of T. cruzi infection in mice. Beclin-1 is a protein essential for autophagy, required for autophago-
some biogenesis and maturation. We have performed an acute model of infection on the
autophagic deficient Beclin-1 heterozygous knock-out mice (Bcln±) and compared to control
Bcln+/+ animals. In addition, we have analyzed the infection process in both peritoneal cells and
RAW macrophages. Our results have shown that the infection was more aggressive in the
autophagy-deficient mice, which displayed higher numbers of parasitemia, heart´s parasitic
nests and mortality rates. We have also found that peritoneal cells derived from Bcln± animals
and RAW macrophages treated with autophagy inhibitors displayed higher levels of infection
compared to controls. Interestingly, free cytosolic parasites recruited LC3 protein and other
markers of xenophagy in control compared to autophagy-deficient cells. Taken together, these
data suggest that autophagy plays a protective role against T. cruzi infection in mice, xenophagy
being one of the processes activated as part of the repertoire of immune responses generated by
the host.
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Eukaryotic cells have three main vesicular pathways for
degradation. Endocytosis and phagocytosis are involved
in the lysis of extracellular proteins and microorganisms,
respectively, whereas autophagy is a self-degradation
pathway wich works to remove intracellular components
such as long-lived proteins and old or damaged orga-
nelles. The autophagic pathway basically comprises the
sequestration of cytoplasmic materials in a double mem-
brane vesicle called autophagosome and the later fusion of
these vesicles with lysosomes to form autolysosomes.
Simple compounds obtained after degradation of macro-
molecules are subsequently transported to cell cytosol and
recycled as energy source substrates or biosynthetic pre-
cursors [1]. Autophagy is a cytoprotective process predo-
minantly activated by stressful physiological stimuli such
as starvation, oxidative stress or high levels of misfolded
proteins contributing to cellular and tissue homeostasis
[2]. Autophagy also participates in processes such as cell
development and remodeling, programmed cell death,
replacement of mitochondria and other organelles, elim-
ination of aggregates of polyubiquitinated proteins and
lipid metabolism [3]. Due to its participation as a quality
control mechanism, autophagy is a higly regulated cellular
process. Excessive or reduced autophagic activity contri-
butes to the development of diseases such as cancer,
neuronal disorders and myopathies, among others [4].
Autophagy has also been implicated in various aspects
of innate and adaptive immunity [5,6], among which the
capture and degradation of intracellular microorganisms
has uncovered a specific antimicrobial role for autophagy.
The events that take place during autophagy are
regulated by the so-called autophagy related genes
(atg genes), which were initially described in yeast. So
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far, 32 genes involved in autophagy in mammals have
been identified [7]. Their products, the ATG proteins,
act sequentially to carry out the specific steps of autop-
hagosome formation and maturation. The process
starts with the formation of the isolation membrane
or phagophore, which expands to entrap the cytoplas-
mic materials and finally closes to form the autophago-
some [8]. Beclin-1, the mammalian homolog of the
yeast Atg6, belongs to the VPS34 (vacuolar protein
sorting 34) complex, a class III phosphatidylinositol
3-kinase (PI3K) complex, required for phagophore for-
mation and enlargement [9–11]. Sequential association
and dissociation of Atgs from the phagophore/autop-
hagosomal membrane allows the maturation of autop-
hagosomes in the autophagic pathway. LC3, the
mammalian homolog of the yeast Atg8, is normally
present as a cytosolic protein (LC3-I) in control condi-
tions. However, upon autophagy induction, this protein
conjugates with phosphatidylethanolamine to form
LC3-II which associates to autophagic vesicles from
the phagophore to the mature autolysosomes being
the best marker for the study of autophagy [12,13].
Therefore, LC3 puncta formation detected by immuno-
fluorescence or the increment of the LC3-II band,
detected by immunoblotting analysis, reflects the exis-
tence of autophagosomes and allows monitoring autop-
hagy. Recruitment and fusion of autophagosomes with
late endosomes and lysosomes lead to the maturation of
autophagic vacuoles in autolysosomes and the degrada-
tion of engulfed materials.
During the infectious processes, autophagy is, in
addition to phagocytosis, a mechanism of the innate
immune response (RII) that contributes to the elimina-
tion of intracellular pathogens [14], such as bacteria
(group A streptococcus, Mycobacterium tuberculosis,
Salmonella enterica, among others), protozoa
(Toxoplasma gondii) and viruses (Chikungunya virus).
In a process known as xenophagy [3], autophagosomes
selectively capture free intracellular pathogens in the
cytosol or inside phagosomes. These microorganisms,
after transiting through the autophagic pathway, are
killed by the lysosomal activity [15]. In the course of
infection, autophagy can be stimulated by pathogen-
associated molecular patterns (PAMPs) that are recog-
nized by pattern recognition receptors (PRRs). The
pathogen is then marked by ubiquitin, which, through
the ubiquitin receptor p62 (SQSTM1), binds to LC3
and triggers the biogenesis of autophagosomes around
the pathogen for its final degradation [16–18]. p62 is an
adaptor protein that binds ubiquitinated cargo via its
UBA domain and ATG8/LC3 via its LIR domain [19].
Trypanosoma cruzi is the causative agent of Chagas
disease, also called American trypanosomiasis, which
was firstly described by the Brazilian doctor, Carlos
Chagas in 1909 [20]. The World Helth Organization
estimates that there are almost 8 millon people infected
with T. cruzi in at least 21 endemic countries of Latin
America (https://www.who.int/chagas/epidemiology/en/
) and the southern part of United States [21]. There
are also a growing number of new cases in non-
endemic countries such as European countries [22],
Canada [23], New Zealand and Australia [24]. The dis-
ease has two clinical forms: an acute phase, followed by
the chronic phase that can occur without an apparent
pathology or clinical manifestations. In the acute phase,
parasitemia levels are high and trypomastigotes, the
infective form of the parasite, can be detected by micro-
scopy in fresh blood preparations. Pericarditis can also
be observed [25]. Parasitemia levels decrease around
90 days of infection. Approximately 30% of patients in
the chronic phase develop cardiac symptoms due to the
persistent presence of amastigotes, the intracellular repli-
cative form of T. cruzi which form the so-called “amas-
tigotes nests” in the myocardical fibers [26].
Using non-phagocytic cells, our laboratory pre-
viously showed that at early stages of T. cruzi infec-
tion, between 1 and 6 hours, trypomastigotes interact
with autophagosomes visualized by the recruitment of
LC3 protein to the T. cruzi parasitophorous vacuole
(TcPV) at these times. The pre-induction of autop-
hagy significantly increased the percentage of infected
cells whereas this parameter was reduced in Atg5 KO
MEFs and in HeLa cells transfected with small inter-
fering RNA against Beclin-1, two situations which
reduce the autophagic response of the host cell [27].
Induction of autophagy also increased the presence of
late endosome/lysosome markers, such as LBPA,
Lamp-1 or cathepsin-D in the TcPV indicating that
the parasite exploits the autophagic pathway to
increase the host cell infection by the lysosomal-
dependent process [28]. Later after infection, when
amastigotes were visualized in the cytoplasm, non-
recruitment of autophagic proteins to parasites was
observed [27]. Likewise, in human fibrosarcoma
derived cells, Onisuka and coworkers found that LC3
did not colocalize with T. cruzi amastigotes. They also
observed that autophagosomes were not matured in
infected cells concluding that T. cruzi inhibits the
autolysosome formation and the parasites were not
enwrapped by autophagosomes in these cells [29].
The main objective of this work was to study the
participation of autophagy in the development of
T. cruzi infection in an in vivo model. We performed
acute T. cruzi infections in Beclin-1 heterozygous
mutated mice (Bcln1±, Bcln KD), which displays
a reduced autophagic response [30], comparing the
152 A. F. CASASSA ET AL.
course of the infection in the controls Bcln1+/+ (Bcln
WT) mice. We also treated WT mice with autophagic
inhibitors such as chloroquine [31,32] and difluoro-
methylornithine (DFMO) [33]. We found that autop-
hagy-deficient mice developed higher parasitemia
values and cardiac parasitic load with a reduced per-
centage of survival compared to control mice. We also
analyzed the infection in peritoneal cells obtained from
these mice, as well as RAW macrophages and con-
firmed the participation of autophagy in the reduction
of T. cruzi intracellular infection. Further cellular stu-
dies with macrophages pointed to xenophagy as one of
the mechanisms for elimination of intracellular para-
sites. We concluded that autophagy participates in the
control of T. cruzi acute infection in mice.
Results
Establishment of a Trypanosoma cruzi acute
infection model in mice.
To study the participation of autophagy during T. cruzi
infection in vivo, we performed a previously standardized
acute model of infection by using young (≈25 days old)
C57BL/6 mice infected with tissue culture derived trypo-
mastigotes (TCT) of T. cruzi Y-GFP strain [34]. At these
conditions, Beclin-1 wild type mice (Bcln+/+) developed
high parasitemia values and lost weight significantly com-
pared with non-infected mice (Figure S1(a)). These ani-
mals died between 14 and 21 days post-infection (dpi) as
a consequence of the acute infection. In contrast, animals
infected at the same conditions with T. cruzi K98,
a previously described chronic strain of T. cruzi [35],
died at later times from around 45 dpi to even 200 dpi
(Figure S1(b)).
Previously published works have demonstrated the pre-
ferential reticular and muscle tissue tropism of T. cruzi
Y strain in mice experimentally infected [36,37]. To con-
firm that our T. cruzi Y-GFP strain has a similar distribu-
tion to the Y wild-type strain and taking advantage that
these parasites express GFP, we performed histology pre-
parations of different tissues and organs from infectedmice
post-mortem and further analyzed by confocal micro-
scopy. As shown in Figure S1(c), amastigote nests were
clearly observed inmany organs and tissues confirming the
extensive distribution of the parasitism. Heart, liver, skele-
tal muscle, lungs and lymphoid organs showed moderate
and high levels of nests abundancy whereas other tissues
displayed low parasitism indicating that T. cruzi replication
was likely not generated at these locations (Figure S1(d)).
Overall, these data indicated that T. cruzi Y-GFP strain
behaved similarly to the parental T. cruzi Y strain and
exhibited comparable histopathology in mice.
Autophagic deficiency increases the rate of T. cruzi
infection in mice
Next we performed the T. cruzi acute infection on
Bcln± mice and compared with Bcln+/+ animals. Since
Beclin-1 is a member of the VPS34 complex required
for autophagosome formation and a functional autop-
hagy pathway [9,10,38], heterozygous disruption of the
Beclin-1 gene (Bcln±) results in a diminished autopha-
gic response in mice [30,38]. Although many condi-
tional knockout mice for Atg genes are available
nowadays, up to date, only Beclin-1 heterozygous mice
express the mutation in the whole organism and are
viable from the postnatal period up to adulthood [39],
resulting in a good tool for our studies. The analysis of
the T. cruzi infection course in the autophagy deficient
mice showed significant differences when compared to
wild type animals. At 5 and 7 dpi, parasitemia values
were higher in Bcln+/+ animals than Bcln±. In contrast,
at subsequent days (10 and 13 dpi), wild type mice
displayed less parasitemia than Bcln± which is evi-
denced by the almost constant values displayed by
Bcln+/+ animals between 7 and 10 dpi (Figure 1(a)).
On the other hand, parasitemia values in Bcln± mice
increased progressively from 5 to 13 dpi (Figure 1(a)).
Of note, survival analysis showed that autophagy defi-
cient animals displayed a significant earlier death
(mean 14.68 SD = 0.3 days) compared to Bcln+/+
(mean 16.70 SD = 0.7 days) (Figure 1(b)). Parasitemia
of Bcln± animals at 10 dpi also correlated with the time
of death (rS = −0.66) suggesting that in these animals,
the increased parasitemia values resulted in an
earlier day of death. Furthermore, post-mortem analy-
sis of myocardial tissues from infected mice, showed
a significantly higher number of amastigote nests in
Bcln± mice compared to Bcln+/+ (Figure 1(c,d)). As
expected, a lower level of Beclin-1 expression was
detected in protein extracts obtained from livers of
uninfected Bcln± mice compared with Bcln+/+
(Figure 1(e)). Concomitantly, LC3-II detection was sig-
nificantly reduced in the knock-down mice livers at
control conditions, consistent with the reduced autop-
hagic activity displayed by these animals (Figure 1(f)).
Inhibition of autophagy enhances T. cruzi infection
in wild type mice
To confirm the effect of the autophagic deficiency on
T. cruzi infection in mice, we studied the outcome of
the infection on the Bcln+/+ mice treated with two
previously described autophagic inhibitors. Wild type
mice were treated once a day with
10 mg/Kg/day chloroquine (CQ) or with 1 mg/g/day
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Figure 1. The deficiency of autophagy exacerbates T. cruzi infection in mice: (a): Parasitemia curve obtained from C57BL/6J wild type
mice (Bcln+/+) and Beclin-1 heterozygous knock-out mice (Bcln±) infected with T. cruzi trypomastigotes of Y-GFP strain as described
in materials and methods (Mann-Whitney test, * p < 0.05, *** p˂0.001). (b): Percentage of survival of Bcln+/+ and Bcln± infected with
T. cruzi Y-GFP. Data were obtained from three independent experiments of at least 4 mice each (log rank Mantel-Cox test, ** p˂0.01).
(c): Cardiac histopathology by H&E staining. Arrows indicate nests of amastigotes. (d): Number of amastigotes nests in cardiac semi-
serial sections. Data were obtained from two independent experiments of at least 4 mice each (Mann-Whitney test, * p < 0.05). (e):
Representative image showing the expression of Beclin-1 in the liver of non-infected Bcln+/+ and Bcln± mice by western blot.
Graphic shows the OD of Beclin-1 band relative to β-Actin expression. Bars indicate the mean ± the standard error of two
independent experiments with at least 2 mice each (Student´s t-test, * p < 0.05). F: Representative image showing the expression
of LC3 forms in the liver of non-infected Bcln+/+ and Bcln± mice by western blot. Graphic shows the OD of LC3-II relative to β-actin
expression. Bars indicate the mean ± the standard error of two independent experiments of at least 2 mice each (Student´s t-test, *
p < 0.05).
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difluoromethylornithine (DFMO), from 2 days before
infection until death (see details in Material and
Methods). As mentioned above, the lysosomotrophic
agent CQ is a potent autophagic flux inhibitor in vivo
[31,32]. Additionally we tested the effect of DFMO, an
inhibitor of the ornithine decarboxylase enzyme
(ODC) that strongly reduces the intracellular level of
spermidine, a polyamine that induces autophagy in
several eukaryotic organisms [40]. This compound
was previously described by our laboratory as a safe
autophagic inhibitor which decreased the autophagic
response in vitro by reducing the expression of Atg
genes [33]. In agreement with our previous data, ani-
mals treated with DFMO showed a significant reduc-
tion in the total LC3 and Atg5 protein levels in livers
when compared with untreated Bcln+/+ mice (Figure
S2(a,b)). Additionaly DFMO treatment significantly
reduced the amount of Beclin-1 (Figure S2(c)).
Similar to Bcln KD mice, Bcln WT animals treated
with the autophagic inhibitors reached higher
parasitemia values at the end of the infection period
(Figure 2(a,e)) and displayed an earlier death com-
pared to the controls (Figure 2(b,f)). Cardiac amasti-
gotes nests also increased in the treated mice
(Figure 2(c,g)) demonstrating the higher level of infec-
tion displayed in conditions which inhibit autophagy.
To control the autophagic response in treated mice the
presence of LC3-II in livers normalized to tubulin was
quantified. As expected CQ treatment increased the
LC3-II/tubulin ratio by inhibition of autophagic flux
whereas DFMO significantly decreased it, two opposite
mechanisms which produced a similar effect of reduc-
tion of autophagy in treated mice (Figure 2(d,h)).
Overall, these findings indicated that in contrast to
the results obtained previously on cultured cells, the
impairment of the autophagic activity in mice (by gene
disruption or inhibitory compounds) enhanced the
systemic infection of T. cruzi demonstrated by
a higher parasitemia and cardiac load and an earlier
death.
Figure 2. Inhibition of autophagy increases T. cruzi infection in Bcln+/+ mice. C57BL/6J wild type mice (Bcln+/+) were treated with CQ
(10 mg/Kg/day) and DFMO (1 mg/g/day) for two days before infection and throughout the experiment as described in materials and
methods. (a and e): Parasitemia curves obtained from these animals in comparison with non-treated Bcln+/+ mice. Data were
obtained from three independent experiments of at least 4 mice each (Mann-Whitney test, * p < 0.05). (b and f): Survival analysis.
Data were obtained from three independent experiments of at least 4 mice each (Log rank Mantel-Cox test) (c and g): Number of
amastigotes in cardiac tissue from control and treated mice. Data were obtained from two independent experiments of at least 4
mice each (Mann-Whitney test, * p < 0.05). (d and h): Representative images showing the expression of LC3 forms in the liver of
non-infected control or treated Bcln+/+ mice by western blot. Graphics show the OD of LC3-II relative to tubulin expression. Bars
indicate the mean ± the standard error of two independent experiments of at least 2 mice each (Student´s t-test, *** p < 0.001).
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Autophagy plays a role in the innate immune
response against T. cruzi
Given that trypomastigotes were inoculated to animals by
IP injection, we next characterized the infection in peri-
toneal cells (PC), the primary focus of infection in our
system. As explained in Materials and Methods, these
cells were obtained by a careful washing of the peritoneal
cavity of healthy Bcln+/+ and Bcln± animals, plated and
then infected in vitro during 24 h before fixation. Other
samples of PC from Bcln+/+ mice were treated in the
presence of 1 mM DFMO or 20 μM CQ from 2 h before
infection until 24 h (Figure 3(a)). After fixation all sam-
ples were processed by confocal microscopy analysis. PC
cytoplasm and nucleus were labeled with TRITC-
phalloidin and Hoechst respectively, whereas intracellular
parasites were directly visualized in green due to the stable
expression of TcH2b histone fused to GFP [41]
(Figure 3(b)). Interestingly, PC obtained from Bcln± or
from Bcln+/+ and treated with inhibitors displayed signif-
icantly higher infection than cells obtained from Bcln+/+
animals maintained in control conditions (Figure 3(b,c)),
indicating that a reduced autophagic activity was related
to higher infection in peritoneal cells. In agreement with
the results obtained with animals, experiments with peri-
toneal cells showed that autophagy is a process which
participates in the control of T. cruzi infection.
In our experimental model, innate immunity is the
main component of the immune response since mice
develop an acute infection and die at very early times
after infection. Several reports in the literature have
demonstrated that macrophages are the first line of
defense against T. cruzi suppressing parasite replication
and spreading in host tissues during the acute phase of
infection [42]. Furthermore, 30% of peritoneal cells are
naïve residentmacrophages [43] indicating that one of the
first targets of T. cruzi in our model were peritoneal
macrophages. Taken these considerations, we next ana-
lyzed the course of T. cruzi infection in macrophages by
performing kinetic experiments in RAW cells, a murine
macrophage cell line. Cells were infected with TCT from
the Y-GFP strain during 24 h. After this period of time,
extracellular parasites were removed by washing and one
coverslip, corresponding to the first time point (24 h), was
immediately fixed. The other samples were incubated in
control medium for an additional period to complete
a total assay time of 48 and 72 h before fixation. In
another set of experiments, cells were incubated with the
autophagy inhibitors DFMO or CQ for 2 h and main-
tained in the same conditions during the infection and
chase (± treatment) before fixation (Figure 4(a)). After
fixation, samples were processed and analyzed by confo-
cal microscopy (see Materials and Methods).
Interestingly, in control conditions (untreated cells) we
observed a progressive reduction in the infection from
early (24 h) to later times (72 h) after infection, whereas
the number of macrophages was almost not modified at
these times. Quantification studies showed a significant
decrease in the percentage of infected cells from 24 to 48
and 72 h after infection (Figure 4(b)). In contrast, in the
presence of autophagy inhibitors we observed a bigger
infection compared to control (Figure 4(c)). Quantitative
data confirmed a significant increase in the percentage of
infection under DFMO and CQ treatment compared to
cells under control conditions at each time (Figure 4(d)).
Taken together these data indicated that macrophages are
able to clear the intracellular parasites through the course
of the infection, autophagy being one of the mechanisms
involved in this elimination.
After invasion of cells, trypomastigotes transiently
reside in a vacuole which membrane is then degraded
to release the parasites to the cytoplasm. Cytosolic
trypomastigotes differentiate into amastigotes which
then initiate their multiplication. At this point we
were interested in determining whether T. cruzi amas-
tigotes could be captured by autophagy in the cyto-
plasm of infected macrophages. To this end we
conducted experiments similar to the one described
above. RAW cells were infected for 24 h and, after
removal of non-internalized parasites; cells were incu-
bated for an additional time of 24 h to allow the
progression of the T. cruzi intracellular cycle, in the
presence or not of the autophagic inhibitors. After
fixation, cells were processed to detect the LC3 protein
by indirect immunofluorescence, and analyzed by con-
focal microscopy. As shown in Figure 5(a), we found
T. cruzi amastigotes (labeled in green and blue) deco-
rated with LC3 (labeled in red). This recruitment was
observed in aproximately 25% of the parasites when
cells were maintained without inhibitors but signifi-
cantly decreased under DFMO and CQ treatment indi-
cating that a functional autophagy is required for the
association of LC3 to amastigotes (Figure 5(b)). As
mentioned in the introduction, LC3 positive vesicle
engulfment of a pathogen and the further elimination
of it through the autophagic pathway is known as
xenophagy [16–18]. Therefore, the possible recruitment
to amastigotes of other proteins related to xenophagy
was determined. Besides LC3, we found that p62 and
NDP52, two adaptors previously described in the bind-
ing of LC3 to pathogens, were highly recruited at 48 h.
At earlier times (24 h) we also found ubiquitin, the first
molecule that recognizes and binds to pathogens
(Figure 5(c)). Taken together, these data indicated
that, by engagement of xenophagy, autophagy partici-
pates in the elimination of T. cruzi in macrophages.
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Discussion
Autophagy is a degradative pathway involved in several
homeostatic processes. As detailed in the introduction,
an important body of evidences indicates that autop-
hagy is also a component of the immune system, being
involved in both innate and adaptive responses [44].
T. cruzi is the parasite that causes Chagas disease, one
of the most widely spread infective illnesses in the
world which impairs the health of wide populations
and generates enormous economic costs. Previous
in vitro studies from our laboratory demonstrated that
autophagy is a key element during infection caused by
T. cruzi in non-phagocytic cells. By live-cell microscopy
we showed the recruitment of LC3 positive vesicles to
the sites of entry of T. cruzi. LC3 protein was also
observed at the membrane of the TcPV [27].
Induction of autophagy previous to infection enhanced
parasite colonization by increasing the number of lyso-
somes which, in turn, leads to the internalization and
the maturation of the parasitophorous vacuole, an
essential process to retain the infection inside host
cells [28]. Later studies also demonstrated that inhibi-
tion of autophagy by treatment with DFMO impaired
T. cruzi infection [33]. Considering these previous stu-
dies, we have speculated that the impairment of the
normal autophagic response, during the infection with
T. cruzi in a mouse model, would benefit the host by
a reduction of the capacity of parasites to internalize
and maintain inside host cells. Surprisingly, mice defi-
cient in autophagy underwent a more aggressive infec-
tion, displaying higher values of parasitemia and
cardiac parasitism that lead to an earlier death. In
agreement with these results, a previous study showed
that M. tuberculosis infection of Atg5 conditional knock
Figure 3. Inhibition of autophagy increases T. cruzi infection in peritoneal cells. Peritoneal cells were isolated by lavage of the
peritoneal cavity of Bcln+/+ or Bcln± mice and then infected with T. cruzi (MOI = 10) for 24 h before fixation. Samples, were then
stained with TRITC-phalloidin and Hoechst and processed by confocal microscopy (see details in materials and methods). Other
samples from Bcln+/+ mice were treated with 20 μM CQ or 10 mM DFMO from 2 h before and during infection and then processed as
above. (a): Scheme of the infection protocol. (b): Representative images depicting the level of cellular infection under the indicated
conditions. Parasites were visualized in green, actin cytoskeleton in red and the nuclei in blue. Bars: 5 µm. (c): Percentage of infected
cells in the indicated conditions. Bars indicate the mean ± the standard error of at least three independent experiments. Number of
counted cells: 100 to 300 cells each experiment (Dunnet test, * p < 0.05; ** p < 0.01).
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out mice resulted in increased bacillary burden and
excessive pulmonary inflammation compared to autop-
hagy-proficient littermates [45].
Interestingly, the curve of parasitemia of WT ani-
mals can be divided in three periods; at early times after
infection (5 and 7 dpi) has a high slope and reaches
higher values, statistically significant, than Beclin-1 KD
mice or WT animals treated with the autophagic
inhibitors, CQ and DFMO. In the second period,
between 7 and 10 dpi, the curve is flattened (low
slope) and later, between 10 and 13 dpi, climbed
again with a slope similar to the first period. In con-
trast, autophagy deficient mice exhibited
a progressively increased curve with a similar slope
for the whole studied period. The strikingly constant
parasitemia values (at 7 and 10 dpi) of Beclin+/+ mice
Figure 4. Autophagy participates in the control of T. cruzi infection by macrophages. RAW macrophages were infected for 24 h,
washed and fixed or incubated for 24 or 48 h more before fixation. Fixed samples were then processed for microscopy (see details in
materials and methods). Other samples were treated with 10 mM DFMO or 20 μM CQ for 2 h before infection (pre-treatment) and
maintained in the same conditions during infection and chase periods followed by fixation and processing. (a): Scheme of the
protocol. (b): Percentage of macrophages infected at progressive times in control conditions. Bars indicate the mean ± the standard
error of at least four independent experiments. Number of counted cells: 100 (Tukey test, *p < 0.05; **p < 0.01). (c): Representative
images depicting the level of cellular infection at 24 h under the indicated conditions. Parasites were visualized in green, actin
cytoskeleton in red and the nuclei in blue. Bars: 5 μm. (d): Percentage of infected cells in the absence (control) or the presence of the
autophagic inhibitors DFMO or CQ at each indicated time. Bars indicate the mean ± the standard error of at least three independent
experiments. Number of counted cells: 100 to 300 cells each experiment (Tukey test, * p < 0.05; **p < 0.01; ***p < 0.001).
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suggested the presence of an active antiparasitic
response of these animals that was not observed in
Beclin± mice or in the presence of inhibitors of
autophagy which displayed a constant increment of
the values of parasitemia accordingly to the progress
of the infection. Unexpectedly, WT animals displayed
Figure 5. Macrophages eliminate intracellular parasites by xenophagy. RAW macrophages were infected for 24 h, washed and
incubated for an additional period of 24 h in control medium or in the presence of 20 μM CQ or 1 mM DFMO before fixation. Fixed
cells were then processed to detect LC3, ubiquitin, p62 or NDP52 by indirect immunofluorescence (see details in materials and
methods). (a): Images depicting intracellular parasites (visualized in green and blue) surrounded by LC3 protein (in red). Insets show
LC3 position of four different stacks of an amastigote. Bars: 5 µm. (b): Percentage of parasites surrounded by LC3 at different
conditions. Bars indicate the mean ± the standard error of at least three independent experiments. Number of counted cells: 100 to
300 cells each experiment (Dunnet test, ***p < 0.001). (c): Images depicting different autophagy/xenophagy markers (in red)
recruited to T. cruzi amastigotes (in green and blue).
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higher values of parasitemia trough the first stage of
infection until 7 dpi, indicating that, although in
experiments with isolated peritoneal cells from Beclin-
1 KD mice showed an increased infection compared to
WT, some delay is produced perhaps in the exit of
parasites from the cells in the first infective cycle, or
alternatively, in the transit required to reach the blood-
stream in KD animals. Indeed, it has been demon-
strated that the macrophage migration inhibitory
factor MIF, a cytokine previously described as
a component of the primary response against T. cruzi
[46], triggered autophagic degradation of junction pro-
teins and increased the permeability of human
endothelial cells [47]. It is possible that KD mice dis-
played an impaired response to MIF and vascular per-
meability is not increased as efficiently as in WT
animals resulting in a minor (or delayed) exit of para-
sites to the bloodstream. More experiments will be
necessary in the future to confirm this hypothesis.
Independently of these initiall differences, all animals
finally die due to the acute infection; however, WT
animals died at later times displaying a greater ability
to resist the infection.
To disclose the possible mechanisms of this resis-
tance to infection, we focus our study in the function of
macrophages. These cells are the first line of defense
against T. cruzi in acute infections [42] and are also
present in the peritoneal cavity, the site of initial infec-
tion. In agreement with the animal parameters, perito-
neal cells from WT animals showed a lower infection
than both Beclin±cells and WT cells treated with
DFMO or CQ. Infection of RAW cells was also signifi-
cantly decreased when compared early to later times,
which highlight their ability to fight T. cruzi. In con-
trast, inhibition of autophagy impaired this antiparasi-
tic activity evidenced by the increased infection
measured in these cells subjected to DFMO or CQ
treatment.
It has been described that autophagy participates in
the innate immune responses by sequestering intracellu-
lar pathogens to further degradation inside autolyso-
somes [16]. This process, so-called xenophagy, was
described for both intraphagosomal bacteria and cyto-
plasmic-living pathogens. Although M. tuberculosis pro-
duced a phagosomal maturation arrest to avoid being
killed by lysosomal degradation [48], it was demon-
strated that induction of autophagy on infected macro-
phages suppressed intracellular survival of mycobacteria
in a process dependent on the recruitment of LC3 to the
membrane of mycobacterial phagosomes and the further
colocalization with lytic compartments [49]. In a similar
way, pathogenic group A Streptococcus were enveloped
by autophagosome-like compartments and killed upon
subsequent fusion of these compartments with lyso-
somes [50]. After these seminal studies, many other
intracellular pathogens were found to be tagged for
autophagic degradation demonstrating the crucial role
of xenophagy in the innate immune response [51].
Interestingly we found the LC3 protein surrounding
amastigotes formed at later times of infection, from
24 h towards, suggesting that xenophagy is participat-
ing in the control of T. cruzi infection by macrophages.
We also found ubiquitin and the autophagic receptors
p62 and NDP52, all components of autophagic selective
processes [52]. Toxoplasma gondi, another protozoan
intracellular pathogen was also enveloped by LC3 and
targeted by autophagic degradation in macrophages
activated by the toxoplasmocidal CD40 ligand [53].
We conclude that xenophagy is involved in the elim-
ination of parasites by macrophages and that absence of
autophagy impairs this process resulting in an
increased infection both in cells and organisms. In
addition, other trypanocidal mechanisms could be also
affected by the absence of autophagy. It is known that
oxidative metabolism activated in macrophages after
T. cruzi infection drives nitric oxide generation and
pathogen clearance [54]. As one of the main regulators
of cellular metabolism, autophagy may also be partici-
pating in these oxidative responses of macrophages.
It is interesting to note that the fate of T. cruzi
infection in a cell can be different according to the
class of host cell infected. In contrast to phagocytic
cells that activate an immune response that tend to
control the infection [42]; in non-phagocytic cells,
T. cruzi can survive, replicate and transmit the infection
to other cells. Concerning to autophagy in this context,
Onisuka and co-workers found in a non-phagocytic cell
line that although T. cruzi infection produced an
increased number of autophagosomes in the cells,
amastigotes were not enwrapped by them, suggesting
that the parasite has mechanisms that allows it to evade
the autophagic capture [29]. In agreement with these
results, previous data from our lab showed, in epithelial
cells, an increment of LC3-positive vesicles after
T. cruzi infection [55] and that with the exception of
few cases, LC3 is not recruited to amastigotes at later
times of infection [27]. Eventhough, a different scenario
was observed in macrophages. In these phagocytic cells
we observed that around 25% of amastigotes were sur-
rounded with LC3 and also with some molecular com-
ponents of the xenophagy machinery such as ubiquitin
and the adaptors p62 and NDP52. Taken together,
these findings indicate that macrophages at least par-
tially, can overcome the mechanisms of evasion of
autophagy displayed by T. cruzi. Therefore, the action
of autophagy against T. cruzi in macrophages can
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explain in part the major resistence of WT animals to
infection when compared to autophagic-deficient mice.
We concluded that, in contrast to what occurs in non-
phagocytic cells in vitro, autophagy plays a protective
role against the infection caused by T. cruzi in mice,
being involved in the repertoire of immune responses
generated by the host. Due to chronic Chagas disease
pathology involves the persistence of parasites on spe-
cific tissues (mainly heart) and also the generated
immune response that is responsible of damaging; all
efforts to understand the mechanisms which participate
in the immunity against this parasite will benefit the




Minimum essential medium (α-MEM) and Dulbecco
modified minimal essential medium (D-MEM) was
obtained from Gibco Laboratories (Buenos Aires,
Argentina). Fetal bovine serum (FBS) was purchased
from Natocor S.A. (Córdoda, Argentina). The inhibi-
tors α-difluoromethylornithine (DFMO) and
Chloroquine (CQ) and the TRITC-conjugated phalloi-
din was purchased from Sigma (Buenos Aires,
Argentina). The rabbit anti-Beclin-1 antibody was pur-
chased from Santa Cruz (Santa Cruz Biotechnology,
INC) and the polyclonal rabbit anti-LC3 antibody
from Sigma (Buenos Aires, Argentina). The following
antibodies were also used: anti-Atg5 (Abcam), anti-p62
(Abcam), Anti-ubiquitin (Santa Cruz), anti-β-actin
(Genescript) and the anti-β tubulin (E7) was obtained
from Developmental Studies Hybridoma Bank. The
secondary antibodies Cy3-conjugated anti-mouse and
Cy3-conjugated anti-rabbit were purchased from
Jackson Immuno Research Laboratories, INC, as well
as the antibodies HRP-conjugated anti-rabbit IgG,
HRP-conjugated anti-mouse IgG and HRP-conjugated
Anti-goat IgG. Hybond-ECL nitrocellulose membranes
were from Amersham. The DNA marker Hoechst
33342 was purchased from Life Technologies.
Parasites
Trypomastigotes of the K98 chronic strain [35] were
donated by Dr. Stella Maris González Cappa
(Department of Microbiology, Faculty of Medicine,
University of Buenos Aires, Buenos Aires, Argentina).
For the acute infections, we used trypomastigotes from
the Y-GFP strain. This strain, which express the H2b
histone fused to GFP [41], were generously provided by
Dr S. Schenkman (Department of Microbiology,
Immunology and Parasitology, Federal University of
Sao Paulo, Brazil). Y-GFP metacyclic trypomastigotes
were obtained from the Y-GFP epimastigotes by
in vitro metaciclogenesis following the method
described in Contreras and Figueiredo [56,57].
Metacyclic trypomastigotes were then used to infect
Vero cells from which, TCT were further generated.
TCT from the third replication cycle in Vero cells
were used for animal infection.
Mice
We used C57BL/6J wild-type mice (WT, Bcln+/+) and
mice heterozygous knock-out for the gene Beclin-1
(Bcln KD, Bcln±) [30] of both sex, ≈25 days old, with
an initial weight between 9–12 g [58]. These mice were
generously provided by Dr. Beth Levin (Department of
Microbiology, University of Texas Southwestern
Medical Center, Dallas, TX, USA). The animals were
kept in conditions free of specific pathogens (SPF) and
housed in cages with controlled temperature and
humidity. They were given water and food ad libitum.
Infeccion
The animals were anesthetized with a medium-
duration dose of 50 mg/kg Ketamine and 10 mg/kg
Xylazine, administered intraperitoneally (IP). Then
they were injected by the same route with 100,000
blood trypomastigotes (BT) of T. cruzi K98 strain or
with 100,000 TCT of T. cruzi Y-GFP strain.
Treatment
The treatment was started 2 days before infection and
continued until the day of the animal death. It was
administrated with a syringe into the intraperitoneal
cavity. The CQ was dispensed daily in a dose of
10 mg/Kg/day for each animal, while DFMO was admi-
nistered daily in a dose of 1 mg/g/day. The control
group was treated with 200 μl of saline solution at
a concentration of 9 g/L.
Evolution of infection
Parasitemia was evaluated by counting the parasite
number present in peripheral blood taken from the
tail by direct puncture. At 5 and 7 dpi, mycroscopic
examination was carried out by under cover slips
(24mm x 24 mm), by counting the parasite number in
10 fields (400x) [59]. At 10 and 13 dpi parasitemia was
assessed by counting the parasites in a Neubauer
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chamber [60] and the results were expressed in para-
sites/ml. In the same time periods weights were evalu-
ated for each subject.
Ethics
All animal procedures were cared in accordance with
the Guiding Principles in the Care and Use of Animals
of the US National Institute of Health. All procedures
were approved by the Institutional Animal Care and
Use Committee of the School od Medical Science,
Universidad Nacional de Cuyo (Protocol approval N°
107/2017).
Histopathology
After the death, the following organs were removed:
heart, liver, spleen, thymus, skeletal muscle (quadri-
ceps), lung, kidney and fat. These organs were subse-
quently introduced into a vial containing a buffered
solution of 10% saline formaldehyde to be fixed before
processing. Tissues were then embedded in paraffin,
cutted at 5 µm and stained with Hoechst. Samples
were examined by confocal microscopy using an
Olympus Confocal FV1000 (Japan) and processed
with the program FV10-ASW 1.7.
For the quantification of cardiac amastigotes nests, six
semi-serial sections with 70-μm intervals, were obtained
for each heart and stained with hematoxylin-eosin [61].
Twenty five (25) slices per field were analyzed by conven-
tional microscopy using an Olympus CX31 microscope.
Cell culture
RAW264.7 cells were grown on in D-MEM supplemented
with 10% FBS and antibiotics at 37ºC in an atmosphere of
95% air and 5% CO2. Cells were plated on coverslips in 24
well-plates to 80% confluence before experiments.
Peritoneal Cells (PCs) isolation
PCs were obtained by peritoneal lavage of euthanized
animals (by sedation with Ketamine/Xylazine followed
by cervical dislocation) from uninfected mice. Cells were
harvested from the peritoneal cavity by injecting cold
PBS, centrifuged at 500 g for 5 min at 4°C, and resus-
pended in D-MEM completemedium supplemented with
10% FBS and antibiotics to a final concentration of
1 × 106 cells/ml. The PC suspension was dispensed into
24-well flat-bottom plates and incubated at 37°C, 5%CO2,
for 24 h, to allow the cells, mainly macrophages, to adhere
to the plastic surface, followed by vigorous washing with
PBS to remove nonadherent cells.
Microscopy and indirect inmunofluorescence
RAW cells or PCs were plated (50.000 and 25,000 cells/
well respectively) and incubated in control medium
(D-MEM) in the presence or absence of autophagy inhi-
bitors, 1 mM DFMO [33] or 20 µM CQ [62]. The
infection was carried out with T. cruzi Y-GFP strain in
a 10: 1 ratio. In all cases cells were fixed with a 3%
solution of paraformaldehyde in PBS for 15 min at
room temperature. After washing with PBS, cells were
blocked for 15 min with 50 mM NH4Cl in PBS, permea-
bilized with a 0.2% solution of albumin and 0.1% sapo-
nin in PBS. After permeabilization, LC3, Ubiquitin, p62
or NDP52 proteins were detected by indirect immuno-
fluorescence by using specific antibodies followed by
detection with Cy3 tagged secondaries antibodies before
mounting with Mowiol containing Hoeschst and exam-
ined by confocal microscopy in a confocal Olympus
FV1000 microscope. Alternatively, RAW cells were
stained with rhodamine-phalloidin to facilitate the quan-
tification of the percentage of infected cells.
Autophagy inhibition and infection
RAW or PC grown in control medium were washed
three times with PBS and plated in 24 well-plates. In
some experiments cells were incubated in control med-
ium or in the presence of the drugs for 2 h prior to
infection with T. cruzi Y-GFP (10:1 parasite:cell ratio)
and continued for additional time of 24 h. In other
cases, the cells were infected during 24 h and, after
washing, treated with drugs for an additional time of
24 h or incubated in control medium during 24 or 48 h
before fixation. Cells were then fixed with 3% parafor-
maldehyde solution in PBS for 15 min at room tem-
perature, washed with PBS, and blocked with 50 mM
NH4Cl in PBS. After washing, cells were mounted with
Mowiol containing Hoechst and examined by confocal
microscopy, using an Olympus Confocal FV1000
(Japan). Images were processed with the program
FV10-ASW 1.7. Confocal images of 10 random fields
were quantified, representing around 100 cells per
experiment. Data are presented as mean values and
error bars indicate the SEM from at least three inde-
pendent experiments.
Western blot
Liver protein extracts from healthy mice were used for
western blot studies. The tissue was lysed in
a homogenization buffer (20mM M Tris-HCl pH 8,
250mM saccharose, 0.1M EDTA pH 8.5 and 0.01%
PMSF on ice. Samples were then centrifuged at
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1000 × g for 10 minutes at room temperature, and the
supernatants were used as protein extracts. Equal
amounts of proteins were resolved in 12.5% (for LC3,
Beclin-1 and Atg5) SDS-polyacrylamide gel electro-
phoresis and transferred to Hybond-ECL (Amersham)
nitrocellulose membranes. Afterwards they were incu-
bated in blocking solution (5% non-fat milk, 0.05%
Tween 80 and PBS) for 1 h at room temperature,
washed four times in PBS-Tween 80 (PBS, 0.05%
Tween-80) and incubated with the corresponding pri-
mary antibodies (anti-LC3, anti-Beclin-1 or anti-Atg5),
overnight at 4°C. The membranes were then washed
three times for 10 min each in PBS-Tween 80 and
incubated with peroxidase-conjugated secondary anti-
bodies (Jackson Immuno Research) for 2 hours at room
temperature. After three washes with PBS-Tween 80,
the membrane-bound antibody was visualized by an
enhanced chemiluminescence detection kit from
Healthcare (Amersham, RPN2109) and the band was
detected using Fujifilm LAS-4000 equipment.
Statistic analysis
The data is presented as the mean ± the standard error.
Student’s t test or ANOVA followed by Dunnet’s multiple
comparisons test were used for parametric analyzes
whereas Mann-Whitney test or Kruskal-Wallis test fol-
lowed by the Dunn multiple comparisons test were used
in nonparametric tests. The analysis of mortality was
done by the log-rank [Mantel-Cox] test. In all cases the
analyzes were carried out using Prism (GraphPad soft-
ware, V. 5.0). The significance corresponds to * p < 0.05;
** p < 0.01 and *** p < 0.001.
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